Evidence map›Paper›PMID 41625759›Full record

ArticleFrontiers in medicine2025

Unicentric Castleman disease with paraneoplastic pemphigus in a young woman: a case report.

Guan-Ting Lv, Yi-Hang Zhao, Jia-Li Zhao, Zhi-Yi Zheng, Zi-Jun Liu

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guan-Ting LvDepartment of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Yi-Hang ZhaoDepartment of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Jia-Li ZhaoDepartment of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Zhi-Yi ZhengDepartment of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Zi-Jun LiuDepartment of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The case reports a rare case of a patient diagnosed with unicentric Castleman disease (UCD) with paraneoplastic pemphigus (PNP). According to the literature, surgery is considered the first-line therapy for such patient. Therefore, we collected and analyzed preoperative and postoperative data to evaluate the surgical outcome and prognosis. Case presentation: A 28-year-old female patient had manifested erosions on oral mucosa and fingers for several months. Contrast-enhanced CT imaging revealed an abdominal mass. Histopathology of the lesions revealed lichenoid interface dermatitis. Direct immunofluorescence examination of the skin revealed a reticular deposition of IgG and C3 in the intercellular spaces of the epidermis. According to the latest diagnostic criteria, she was diagnosed with PNP. She underwent surgery at our hospital, during which the mass was completely resected. Postoperative pathology confirmed the mass as UCD, specifically of the hyaline vascular type. Following the surgery, the patient was concurrently treated with a tapering regimen of oral glucocorticoids. After 2 years of follow-up, there was no recurrence of the oral or hand erosions, and a repeat abdominal CT scan showed no evidence of mass recurrence. Conclusion: Complete resection is the first-line therapy for UCD with PNP. Early and correct diagnosis is crucial for patient prognosis.

Indexed as

case reportparaneoplastic pemphigusprognosissurgeryunicentric Castleman disease

Identifiers

PMID41625759
PMCPMC12855139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.